Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 July 2024 | Story Lacea Loader

The University of the Free State (UFS) is co-hosting the Global Social Innovation Indaba together with Social Innovation Exchange (SIX) on its Bloemfontein Campus from 30 September to 2 October 2024. This event brings together people from different sectors all over the world to discuss how to accelerate and support people-powered change and create a better society for generations to come.

The UFS is excited to collaborate with SIX, as its vision and values overlap. During this three-day indaba, aspects such as – what it takes to build accountable, inclusive, and participatory institutions, specifically the future role of universities in South Africa – will be discussed. Themes to be explored include young people as drivers of change, post-industrial transitions and community resilience, the role of art, social change and bridging divides, and systemic approaches to dealing with unemployment.

Some of the speakers and participants in the programme include Carla Duprat from ICE (Brazil); Cheryl Jacob from ESquared Investments (South Africa); François Bonnici from the Schwab Foundation for Social Entrepreneurship (Switzerland); Sir Geoff Mulgan from the University College London (UCL) in the United Kingdom; and Dr Narissa Ramdhani from the Ifa Lethu Foundation (South Africa).

The UFS will also use the opportunity to showcase its campus and offerings to attendees, focusing on its transformation story and some of the interdisciplinary forward-thinking programmes. Guests will also be treated to true South African hospitality, laying the foundation for strong relationships and collaboration.

SIX believes in the transformative power of people working together. Exchanges based on mutual value and reciprocity are the missing link in tackling the world’s problems. As a friendly, expert entry point to global social innovation, their work connects organisations, sectors, communities, and nations to build capabilities and create opportunities for collaboration. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept